Skip to content

Efficacy and Safety of a Purified Standardised Wasp Venom Preparation

Immunotherapy of Wasp Venom Allergy: Comparison of a Purified Preparation to Conventional Aqueous Wasp Venom in an Open Controlled Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00263926
Enrollment
Unknown
Registered
2005-12-12
Start date
2001-03-31
Completion date
2010-11-30
Last updated
2013-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy

Keywords

Wasp venom allergy,, specific immunotherapy

Brief summary

The trial is performed to assess efficacy and safety of a purified standardised wasp venom preparation in wasp venom allergy

Interventions

BIOLOGICALwasp venom

Sponsors

Allergopharma GmbH & Co. KG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* History of wasp venom allergy, * Positive RAST to wasp venom, * Positive skin prick test to wasp venom

Exclusion criteria

* Serious chronic diseases

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026